Literature DB >> 20958217

Differences between cellular and molecular profiles of induced pluripotent stem cells generated from mouse embryonic fibroblasts.

Eun Young Kim1, Kilsoo Jeon, Hyo Young Park, Young Joon Han, Byoung Chul Yang, Soo Bong Park, Hyung Min Chung, Se Pill Park.   

Abstract

Induced pluripotent stem (iPS) cells are a new alternative for the development of patient-specific stem cells, and the aim of this study was to determine whether differences exist between the cellular and molecular profiles of iPS cells, generated using lentiviral vectors, compared to ES cells. The lentiviral infection efficiency differed according to the method of cell culture (adherent cells: 0.085%; suspended cells: 0.785%). Six iPS cell lines exhibited typical ES cell morphology and marker expression, but varied in their in vitro/in vivo differentiation ability. Global gene transcription analysis revealed that core pluripotency genes were expressed at lower levels in iPS cell lines compared to D3-ES cells (Pou5f1: x1.6~2.2-fold, Sox2: x2.58~10.0-fold, Eras: x1.08~2.54-fold, Dppa5a: x1.04~1.41-fold), while other genes showed higher expression in iPS cells (Lin28: x1.43~2.33-fold; Dnmt3b: x1.33~2.64-fold). This pattern was repeated in a survey of specific functional groups of genes (surface markers, cell death, JAK-STAT and P13K-AKT signaling pathways, endothelial, cardiovascular, and neurogenesis genes). Among the iPS cell lines examined, only two showed similar characteristics to ES cells. These results demonstrated that, in addition to cellular characterization, the numerical evaluation of gene expression using DNA microarrays might help to identify the stem cell stability and pluripotency of iPS cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20958217      PMCID: PMC2998986          DOI: 10.1089/cell.2010.0013

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  30 in total

1.  High-throughput screening of gene function in stem cells using clonal microarrays.

Authors:  Randolph S Ashton; Joseph Peltier; Christopher A Fasano; Analeah O'Neill; Joshua Leonard; Sally Temple; David V Schaffer; Ravi S Kane
Journal:  Stem Cells       Date:  2007-08-02       Impact factor: 6.277

2.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

3.  Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells.

Authors:  Yuhki Nakatake; Nobutaka Fukui; Yuko Iwamatsu; Shinji Masui; Kadue Takahashi; Rika Yagi; Kiyohito Yagi; Jun-Ichi Miyazaki; Ryo Matoba; Minoru S H Ko; Hitoshi Niwa
Journal:  Mol Cell Biol       Date:  2006-09-05       Impact factor: 4.272

4.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

5.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

6.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

7.  Global gene expression profiling reveals similarities and differences among mouse pluripotent stem cells of different origins and strains.

Authors:  Lioudmila V Sharova; Alexei A Sharov; Yulan Piao; Nabeebi Shaik; Terry Sullivan; Colin L Stewart; Brigid L M Hogan; Minoru S H Ko
Journal:  Dev Biol       Date:  2007-05-10       Impact factor: 3.582

8.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

Review 10.  Strategies and new developments in the generation of patient-specific pluripotent stem cells.

Authors:  Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

View more
  7 in total

1.  Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining.

Authors:  Jinshui Fan; Carine Robert; Yoon-Young Jang; Hua Liu; Saul Sharkis; Stephen Bruce Baylin; Feyruz Virgilia Rassool
Journal:  Mutat Res       Date:  2011-06-28       Impact factor: 2.433

Review 2.  Regenerating functional heart tissue for myocardial repair.

Authors:  Andre Alcon; Esra Cagavi Bozkulak; Yibing Qyang
Journal:  Cell Mol Life Sci       Date:  2012-03-03       Impact factor: 9.261

Review 3.  Immunological applications of stem cells in type 1 diabetes.

Authors:  Paolo Fiorina; Julio Voltarelli; Nicholas Zavazava
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

Review 4.  The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening.

Authors:  Jaffar M Khan; Alexander R Lyon; Sian E Harding
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

5.  Genetic background affects induced pluripotent stem cell generation.

Authors:  Lauren V Schnabel; Christian M Abratte; John C Schimenti; Teresa L Southard; Lisa A Fortier
Journal:  Stem Cell Res Ther       Date:  2012-08-03       Impact factor: 6.832

6.  Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart.

Authors:  Stephanie Buccini; Khawaja Husnain Haider; Rafeeq P H Ahmed; Shujia Jiang; Muhammad Ashraf
Journal:  Basic Res Cardiol       Date:  2012-10-18       Impact factor: 17.165

7.  A Cationic Stearamide-based Solid Lipid Nanoparticle for Delivering Yamanaka Factors: Evaluation of the Transfection Efficiency.

Authors:  Funda Alkan; Hanife Sevgi Varlı; Murat Demirbilek; Engin Kaplan; Nelisa Türkoğlu Laçin
Journal:  ChemistryOpen       Date:  2020-11-16       Impact factor: 2.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.